[Dasatinib-related pneumonia? An example of pharmacovigilance survey]

A Audemard; B de la Gastine; S Chantepie; H Verger; A C Gac; E Bergot; O Reman

doi:10.1016/j.rmr.2014.08.002

[Dasatinib-related pneumonia? An example of pharmacovigilance survey]

Rev Mal Respir. 2015 Jan;32(1):84-6. doi: 10.1016/j.rmr.2014.08.002. Epub 2014 Sep 26.

[Article in French]

Authors

A Audemard¹, B de la Gastine², S Chantepie³, H Verger⁴, A C Gac³, E Bergot⁴, O Reman³

Affiliations

¹ Service de médecine interne, CHU Côte-de-Nacre, avenue Côte-de-Nacre, 14000 Caen, France. Electronic address: [email protected].
² Centre régional de pharmacovigilance, CHU Côte-de-Nacre, 14000 Caen, France.
³ Service d'hématologie, CHU Côte-de-Nacre, 14000 Caen, France.
⁴ Service de pneumologie, CHU Côte-de-Nacre, 14000 Caen, France.

PMID: 25618211
DOI: 10.1016/j.rmr.2014.08.002

No abstract available

Keywords: Chronic myeloid leukemia; Dasatinib; Drug-induced pneumonitis; Interstitial pneumonia; Leucémie myéloïde chronique; Pneumopathie interstitielle; Pneumopathie médicamenteuse.

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Blast Crisis / complications
Blast Crisis / drug therapy
Cyclophosphamide / administration & dosage
Cytarabine / administration & dosage
Dasatinib
Dexamethasone / administration & dosage
Doxorubicin / administration & dosage
Filgrastim
Granulocyte Colony-Stimulating Factor / adverse effects
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Male
Methotrexate / administration & dosage
Middle Aged
Pharmacovigilance
Pneumonia / chemically induced*
Pneumonia / diagnostic imaging
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / adverse effects*
Pyrimidines / administration & dosage
Pyrimidines / adverse effects*
Recombinant Proteins / adverse effects
Recombinant Proteins / therapeutic use
Thiazoles / administration & dosage
Thiazoles / adverse effects*
Tomography, X-Ray Computed
Vincristine / administration & dosage

Substances

Protein Kinase Inhibitors
Pyrimidines
Recombinant Proteins
Thiazoles
Cytarabine
Granulocyte Colony-Stimulating Factor
Vincristine
Dexamethasone
Doxorubicin
Cyclophosphamide
Filgrastim
Dasatinib
Methotrexate

Supplementary concepts

CVAD protocol